Gam Holding Ag Regeneron Pharmaceuticals, Inc. Transaction History

Gam Holding Ag

$1.14 Billion
Q3 2024

A detailed history of Gam Holding Ag transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Gam Holding Ag holds 2,759 shares of REGN stock, worth $2.22 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

2,759

Previous 2,587 6.65%

Holding current value

$2.22 Million

Previous $2.72 Million 6.66%

% of portfolio

0.26%

Previous 0.22%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$1024.09 - $1201.76 $176,143 - $206,702	172 Added 6.65%	2,759 $2.9 Million
Q2 2024 Jul 26, 2024	SELL	$883.2 - $1071.19 $468,979 - $568,801	-531 Reduced 17.03%	2,587 $2.72 Million
Q4 2023 Jan 23, 2024	SELL	$775.18 - $881.7 $3,875 - $4,408	-5 Reduced 0.16%	3,118 $2.74 Million
Q3 2023 Oct 16, 2023	BUY	$692.45 - $844.37 $7,616 - $9,288	11 Added 0.35%	3,123 $2.57 Million
Q2 2023 Jul 27, 2023	SELL	$700.03 - $830.35 $2,800 - $3,321	-4 Reduced 0.13%	3,112 $2.24 Million
Q1 2023 May 09, 2023	BUY	$680.49 - $826.97 $112,961 - $137,277	166 Added 5.63%	3,116 $2.56 Million
Q4 2022 Feb 02, 2023	SELL	$705.89 - $766.39 $881,656 - $957,221	-1,249 Reduced 29.75%	2,950 $2.13 Million
Q3 2022 Oct 19, 2022	SELL	$573.97 - $724.32 $578,561 - $730,114	-1,008 Reduced 19.36%	4,199 $2.89 Million
Q2 2022 Jul 21, 2022	BUY	$548.35 - $738.84 $2.31 Million - $3.11 Million	4,208 Added 421.22%	5,207 $3.08 Million
Q1 2022 May 06, 2022	SELL	$595.12 - $698.43 $182,701 - $214,418	-307 Reduced 23.51%	999 $698,000
Q4 2021 Jan 26, 2022	SELL	$543.48 - $670.97 $233,152 - $287,846	-429 Reduced 24.73%	1,306 $825,000
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $297,921 - $353,418	-519 Reduced 23.03%	1,735 $1.05 Million
Q2 2021 Aug 09, 2021	SELL	$472.8 - $558.54 $568,305 - $671,365	-1,202 Reduced 34.78%	2,254 $1.26 Million
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $1.54 Million - $1.89 Million	3,456 New	3,456 $1.64 Million
Q4 2020 Feb 10, 2021	SELL	$478.3 - $607.98 $1.69 Million - $2.14 Million	-3,528 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$544.75 - $658.21 $11,439 - $13,822	21 Added 0.6%	3,528 $1.98 Million
Q2 2020 Aug 10, 2020	BUY	$493.32 - $643.92 $1.73 Million - $2.26 Million	3,507 New	3,507 $2.19 Million
Q4 2019 Feb 06, 2020	SELL	$274.13 - $376.51 $554,839 - $762,056	-2,024 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$273.46 - $318.39 $553,483 - $644,421	2,024 New	2,024 $561,000
Q2 2019 Aug 12, 2019	SELL	$299.6 - $414.82 $651,929 - $902,648	-2,176 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$372.08 - $439.57 $337,104 - $398,250	906 Added 71.34%	2,176 $894,000
Q4 2018 Feb 08, 2019	SELL	$335.82 - $403.04 $106,454 - $127,763	-317 Reduced 19.97%	1,270 $474,000
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $557,259 - $648,305	1,587 New	1,587 $641,000
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $6.81 Million - $7.96 Million	-15,788 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	15,788	15,788 $7.75 Million

Others Institutions Holding REGN

# of Institutions

1,512

Shares Held

84.5M

Call Options Held

926K

Put Options Held

1.22M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $86.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.

Account